Abstract-As a potentially viable method of brain drug delivery, the safety profile of blood-brain barrier (BBB) opening using focused ultrasound (FUS) and ultrasound contrast agents (UCA) needs to be established. In this study, we provide a short-term (30-min or 5-h survival) histological assessment of murine brains undergoing FUS-induced BBB opening. Forty-nine mice were intravenously injected with Definity microbubbles (0.05 mL/kg) and sonicated under the following parameters: frequency of 1.525 MHz, pulse length of 20 ms, pulse repetition frequency of 10 Hz, peak rarefactional acoustic pressures of 0.15-0.98 MPa and two 30-s sonication intervals with an intermittent 30-s delay. The BBB opening threshold was found to be 0.15-0.3 MPa based on fluorescence and magnetic resonance imaging of systemically injected tracers. Analysis of three histological measures in hematoxylin and eosin-stained sections revealed the safest acoustic pressure to be within the range of 0.3-0.46 MPa in all examined time periods post sonication. Across different pressure amplitudes, only the samples 30 min post opening showed significant difference (p , 0.05) in the average number of distinct damaged sites, microvacuolated sites, dark neurons and sites with extravasated erythrocytes. Enhanced fluorescence around severed microvessels was also noted and found to be associated with the largest tissue effects, whereas mildly diffuse BBB opening with uniform fluorescence in the parenchyma was associated with no or mild tissue injury. Region-specific areas of the sonicated brain (thalamus, hippocampal fissure, dentate gyrus and CA3 area of hippocampus) exhibited variation in fluorescence intensity based on the position, orientation and size of affected vessels. The results of this short-term histological analysis demonstrated the feasibility of a safe FUS-UCA-induced BBB opening under a specific set of sonication parameters and provided new insights on the mechanism of BBB opening.
INTRODUCTION
Effective delivery of therapeutic agents to the brain has been hindered mainly by the presence of the blood-brain barrier (BBB), which is a complex regulatory system within the neurovascular unit that maintains brain homeostasis by controlling the flow of nutrients and chemicals into and out of the brain parenchyma (Abbott et al. 2006) . Lipid solubility, molecular size and charge are some of the determining factors for the passage of molecules across the BBB (Habgood et al. 2000) . Based on these criteria, at least two types of permeability barriers exist at the BBB: (i) a physical paracellular barrier at the tight junctions (TJ) of the endothelial cells that prevents the passage of molecules (.180 Da) through the interendothelial clefts (Kroll and Neuwelt 1998) ; and (ii) a chemically-selective transcellular barrier at the plasma membrane of endothelial cells that controls molecular transport by using carrier-mediated, receptor-mediated and active efflux transporters, as well as endocytotic vesicular pathways (Zlokovic 2008) . Thus, an effective delivery of pharmacological agents to the brain requires successful passage across at least one of these two barriers.
Despite some limited success, currently available drug delivery methods fail to simultaneously satisfy two desirable outcomes: a localized delivery and a noninvasive procedure. One example is the intra-arterial injection of hyperosmotic solutions such as mannitol (Kroll and Neuwelt 1998; Lossinsky et al. 1995; Rapoport 1996) that causes the shrinkage of endothelial cells and provides a paracellular passage for the drug. Another method is the chemical modification of drugs by lipidization or conjugation to genetically engineered molecular Trojan horses, promoting transcellular passage via lipidmediated diffusion or receptor-mediated transport, respectively (Fischer et al. 1998; Pardridge 2002 Pardridge , 2005 . Both of these methods are noninvasive, but they cause diffuse BBB opening and undesirable drug distribution to nontargeted areas of the brain. Other approaches such as convection-enhanced diffusion and intracranial injection (Bobo et al. 1994; Weaver and Laske 2003) provide a more localized delivery of the drug but involve an invasive neurosurgical operation that may lead to hemorrhage, inflammation and neuronal damage.
An ideal drug delivery method to the brain would require a localized and temporary disruption of the BBB, with minimal damage to the surrounding tissue. Multiple studies have shown that focused ultrasound (FUS) can open the BBB in the central nervous system (CNS) (Bakay et al. 1956; Ballantine et al. 1956; Mesiwala et al. 2002) . In recent years, researchers have used FUS in conjunction with ultrasound contrast agents (UCA, preformed microbubbles) to disrupt the BBB locally, noninvasively and transiently (Hynynen et al. 2001; Choi et al. 2007b; Hynynen 2008) . Our group along with others have shown feasibility of transcranial FUS application with successful BBB opening at the targeted region in wild-type and transgenic mice (Choi et al. 2007b , and in larger animal models such as rats, rabbits and pigs (Hynynen et al. 2001; Xie et al. 2008; Yang et al. 2007 ). In addition, molecular delivery of several tracer compounds and therapeutic agents into the brain have been shown and studied, including dextrans Wang et al. 2008) , gadolinium (Choi et al. 2007a; Hynynen et al. 2001) , horseradish peroxidase , immunoglobulin G (Sheikov et al. 2004) , Herceptin (Kinoshita et al. 2006a) , doxorubicin (Treat et al. 2007 ), anti-amyloid antibody (Raymond et al. 2008 ) and dopamine D 4 receptor antibody (Kinoshita et al. 2006b ).
Although the exact mechanism of BBB opening remains to be determined, the interaction of the ultrasound beam with microbubbles results in mechanical changes in the microvasculature and thereby changes in the integrity of the BBB components. Previous studies suggest that both paracellular and transcellular barriers are affected during and after FUS-UCA interaction (Sheikov et al. 2004) . There is evidence that a redistribution and loss of immunosignals at the TJ proteins (such as occludin, claudin-5 and ZO-1) occurs up to four hours after the sonication. Moreover, the vesicular transport of tracer molecules across the endothelial cells increases, contributing to further penetration of these molecules into the basement membrane, surrounding pericytes, arteriole smooth muscle cells and perivascular neuropil (Sheikov et al. 2008) . Although these changes in BBB integrity are reversible under the conditions of the aforementioned studies, the damaging impact of such anatomical and physiological modification remains to be thoroughly assessed.
Under specific sonication parameters, recent safety studies by some groups have shown BBB disruption with minimal or negligible damage to the vasculature and the surrounding tissue McDannold et al. 2005 McDannold et al. , 2007 Yang et al. 2007) . Although it is difficult to make accurate comparisons among different studies because of the subjective nature of histological assessment and variations in experimental parameters and procedures, some broad conclusions can be summarized from previously reported findings. So far, short-term and long-term assessments have been performed on animals (mice, rats and rabbits) sacrificed four hours to four weeks after sonication. In general, lowerfrequency FUS along with lower pressure amplitudes and lower UCA doses have been shown to result in reduced tissue injury McDannold et al. 2007; Yang et al. 2007 ). The histological damage has been mostly limited to few isolated or clusters of red blood cell (RBC) extravasations and few apoptotic neurons. Although a few studies have attempted to associate certain sonication parameters with specific microscopic damage Yang et al. 2007) , additional safety studies are warranted to investigate optimal sonication parameters that result in the delivery of clinically relevant doses of therapeutic agents with no or minimal associated bioeffects.
In this study, we aim at adding new information to the existing reports on the safety of the FUS-UCA interaction using a different combination of values for sonication parameters (frequency 1.525 MHz, pulse length 20 ms, pulse repetition frequency [PRF] 10 Hz, duration 2 30-s sonication intervals with 30-s delay in between, peaknegative pressures of 0.3 to 0.98 MPa) with Definity (Bristol-Myers Squibb Medical Imaging Inc., North Billerica, MA, USA) microbubbles. Under these conditions, we have (i) assessed the safety profile of the technique more comprehensively by evaluating and quantifying three histological criteria and one composite measure of damage, (ii) described short-term effects of the procedure on mice sacrificed 30 min or 5 h after sonication, (iii) characterized the relationship between BBB disruption and tissue injury to identify any correlation between highly concentrated fluorescence (detected in previous studies) and neurovascular damage and (iv) determined variability in BBB opening and microscopic damage in region-specific areas of the brain such as the hippocampus and the thalamus.
Our experiments are also unique with respect to the ease of comparison with the control unsonicated region (right hippocampus) and perhaps in offering a greater objectivity in assessing BBB opening and histological damage. The unique shape of the hippocampus along with the nearby ventricles, the rich distribution of the vasculature in the hippocampal formation, the unique arrangement of neuronal cell bodies in pyramidal and granular layers of the hippocampus and the symmetric position of the right and left hippocampi in horizontal sections all contribute to the useful characteristics of the hippocampal region as a targeted area. Our results provide new insights on the mechanism and safety of BBB opening while reinforcing previous findings, i.e., using an appropriate combination of sonication parameters can result in BBB opening with no or negligible tissue effects within a short time period after the sonication.
MATERIALS AND METHODS

Animals and anesthesia
All animal procedures were approved by the Columbia University Institutional Animal Care and Use Committee. Fifty-two adult male mice were used for this study (CB57L/6 strain, 18 to 31 g; Harlan, Indianapolis, IN, USA). The animals were anesthetized with a mixture of oxygen (0.8 L/min at 1.0 Bar, 21 C) and 1.5-2.0% vaporized isoflurane (Aerrane, Baxter Healthcare Corporation, Deerfield, IL, USA) using an anesthesia vaporizer (Model 100 Vaporizer, SurgiVet, Inc., Waukesha, WI, USA). The mouse's vital signs were continuously monitored (respiration rate 50 to 80 per min) and isoflurane was adjusted throughout the experiment as needed. The mouse was kept warm using an infrared heating lamp at all times.
Ultrasound setup
A single-element circular-aperture FUS transducer (center frequency 1.525 MHz, focal depth 90 mm, outer radius 30 mm, inner radius 11.2 mm) with a pulse-echo transducer in its center was used for sonication (Choi et al. 2007b) . A single-element, pulse-echo transducer (center frequency 7.5 MHz) with a focal length of 60 mm was positioned through the center hole of the FUS transducer so that the foci of the two transducers could be properly aligned. The pulse-echo transducer was driven by a pulser-receiver system (Model 5800, Panametrics, Waltham, MA, USA) connected to a digitizer (CS8349, Gage Applied Technologies, Inc., Lachine, QC, Canada). A cone filled with degassed and distilled water and capped with an ultrathin polyurethane membrane with ultrasound transparency (Trojan; Church & Dwight Co., Inc., Princeton, NJ, USA) was mounted on the transducer system (Fig. 1a) .
The FUS transducer was attached to a computercontrolled 3-D positioning system (Velmex Inc., Lachine, QC, Canada) and was driven by a function generator (3320A, Agilent Technologies, Palo Alto, CA, USA) through a 50-dB power amplifier (325LA, ENI Inc., Rochester, NY, USA).
As previously described (Choi et al. 2007b) , the acoustic pressure of the FUS transducer was measured with a needle hydrophone (HP Series, Precision Acoustics Ltd., Dorchester, Dorset, UK; needle diameter 0.2 mm) in a water tank filled with degassed water. The obtained values were then corrected using the attenuation values of the skull (Choi et al. 2007b) . As determined in that study, the mouse skull attenuated the acoustic pressure by 18.1 6 1.5% (n 5 5) through the parietal bone. The dimensions of the beam were measured to have a lateral and axial full-width at half-maximum (FWHM) intensity of approximately 1.32 and 13.0 mm, respectively.
Targeting procedure
Anesthetized mice were placed prone on a platform and their heads were immobilized using a stereotaxic frame. The fur on the head was removed with an electric razor and a depilatory cream. A small container was filled with degassed and distilled water and suspended over the mouse's head (Fig. 1c) . The bottom part of the container consisted of a thin plastic membrane that was acoustically and optically transparent (Saran; SC Johnson, Racine, WI, USA). Ultrasound gel was then used to couple the thin plastic membrane with the mouse skin (Fig. 1a) .
We used a grid positioning method to target the mouse hippocampus (Choi et al. 2007b) . For this purpose, the sutures of the mouse skull were identified and used as anatomic landmarks (Fig. 1c) . The location of the hippocampus relative to the sutures was identified based on the known mouse brain and skull anatomy. A grid was constructed from three 0.3-mm thin metal bars. Two were placed parallel to each other and separated by 4 mm, and the third bar was soldered perpendicular to the other two through their center plane (Choi et al. 2007b) . The grid was placed at the bottom of the water container, on top of the skull, and in alignment with the sutures visible through the skin (Fig. 1c) . The center bar was aligned along the sagittal suture and one of the parallel bars was in alignment with the lambdoid suture. Utilizing the pulse-echo transducer, a lateral 2-D raster scan of the grid was generated. The transducer's beam axis was then positioned 2.25 and 2 mm away from the sagittal and lambdoid sutures, respectively (Fig. 1b) . Finally, the focal point was placed 3 mm beneath the top of the skull so that the acoustic wave propagated through the left parietal bone and overlapped with the left hippocampus and a small portion of the lateral region of the thalamus. Using this grid-positioning system, precise and reproducible targeting of the hippocampus of the murine brain was performed (Choi et al. 2007b ).
Microbubble injection and sonication
For each series of experiments performed on the same day, a new vial of Definity microbubbles was first activated using the manufacturer's instructions. Definity microbubbles are composed of octafluoropropane gas encapsulated in a lipid shell, with a reported diameter of 1.1-3.3 mm and mean concentration of 1.2 3 10 10 bubbles per mL. After activation, a 1:20 dilution of Definity was prepared using 1x phosphate-buffered saline (PBS) and then injected immediately into the tail vein (50 mL of original concentration per kilogram of mouse body mass). The targeted left hippocampus was then sonicated 1 min later using the pulsed-wave FUS (PRF 10 Hz, pulse length 20 ms, duty cycle 20%) in two 30-s sonication intervals with an intermittent 30-s delay. The 1-min delay between the microbubbles injection and sonication was selected for consistency with our previous experiments. Initially, the reason was to allow the microbubbles to circulate more homogeneously in the bloodstream rather than being concentrated in one region and diluted in another. The 30-s pause between the two sonications was to allow the dissipation of the generated heat from the first sonication. Peak rarefactional acoustic pressures of 0.15, 0.30, 0.46, 0.61, 0.75, 0.90 and 0.98 MPa were used. The right hippocampus was not targeted and was used as control. We examined the presence and the extent of BBB opening at the sonicated location using the injected fluorescenttagged dextrans (n 5 28) or magnetic resonance imaging (MRI) contrast agent gadolinium (n 5 17).
MRI
Each mouse (n 5 17) was immobilized in a 3.8-cmdiameter birdcage coil and inserted in a vertical bore 9.4-Tesla MR system (DPX400, Bruker Medical, Boston, MA, USA). One to 2% isoflurane was administered while the respiration rate of the mouse was monitored throughout the procedure. About 90 min post sonication (delay because of transportation and setup time), in vivo T1-weighted horizontal images of the mouse brain were then sequentially acquired (TR/TE 246.1 ms/10 ms, bandwidth 50 kHz, 505.1 Hz, number of excitations 5, matrix size 256 3 256, field of view 1.92 3 2.14 cm, slice thickness 0.6 mm) before (3 images, duration 12 min) and after (21 images, duration 90 min) injection of an MRI contrast agent. The agent was a gadolinium-based, BBB-impermeable compound (Omniscan, Amersham Health, AS Oslo, Norway, amount 0.75 mL, molecular weight 573.7 Da) and was administered intraperitoneally (IP) via a catheter to depict the BBB opening. IP injection allowed for the slow uptake of the MRI contrast agent into the bloodstream, and hence made it more amenable to the low MR temporal resolution. MRI scans used in this study were acquired 150 min post sonication (60 min post gadolinium injection) and they correspond to peaking of the MR intensity as determined by our previous studies (Choi et al. 2007a (Choi et al. , 2007b .
Tracer injection and perfusion
To determine the actual sonicated location and to verify BBB opening at the targeted region, a bolus injection of 3 kDa lysine-fixable Texas Red (TR) dextrans (Molecular Probes Inc.; Eugene, OR, USA) was followed 10 min after sonication (n 5 28). The tracer was dissolved in 1x PBS (0.2 mL) to a final concentration of 80 mg/kg of mouse body mass and injected into the femoral vein. A circulation time of either 30 min (n 5 13) or 5 h (n 5 15, 5 of which MRI was used to confirm the opening) was allowed depending on the experiment. The total number of studied sections per brain was 24 in the control (0 MPa) and 56 in the sonicated cases (0.3 to 0.75 MPa). The animals were subsequently sacrificed and transcardially perfused with PBS (4 to 5 min.) and 4% paraformaldehyde (7 to 8 min) at a flow rate of 6.8 mL/min. Next, the skull was removed and the brain was immersion-fixed for 24 h before extracting the brain. The brain was fixed again in 4% paraformaldehyde for 48-120 hours before sectioning.
Histology and microscopy
For microscopic evaluation, the post-fixation processing of the brain tissue was performed according to standard histological procedures. The paraffin-embedded specimen was sectioned horizontally at 6-mm thickness in 12 separate levels that covered most of the hippocampus. To reach the targeted hippocampal formation, 1.2 mm from the top of the brain was trimmed away and discarded. At this first level, six sections were acquired, spanning over 36 mm of brain tissue. Another 80 mm of tissue were discarded and the process was repeated for another 11 levels, totaling 72 sections. For each level, the first two sections were stained with hematoxylin and eosin (H&E), whereas four other unstained sections were used for fluorescence imaging of TR dextrans and for additional future staining and assays. Bright-field and fluorescence images were acquired using two microscopes (BX61 and IX-81; Olympus, Melville, NY, USA) that provided both light and fluorescence imaging, with a filter set at excitation and emission wavelengths of 595 nm and 615 nm, respectively.
Determining BBB opening threshold
Occurrence of the BBB opening was assumed when associated with fluorescence or contrast enhancement at the targeted site (left hippocampus) compared with the control (right hippocampus). Only sonicated hippocampi with a clear diffusion of the tracer compound into the parenchyma were considered to have undergone BBB opening. Hence, a greater amount of fluorescence in the arterioles or larger vessels was insufficient in confirming BBB opening. The threshold for opening was determined as the lowest peak negative pressure, which resulted in BBB opening in more than 50% of the sonicated samples.
Safety assessment: Gross examination
To identify and exclude easily evident, damageinducing pressures from future consideration, a gross examination was performed on the brains of four mice before the study (sonicated with acoustic pressures of 0.46, 0.61, 0.75 and 0.98 MPa). Brains were sectioned horizontally into three slices (1.7 mm each) and examined for detectable hemorrhage under a low-power microscope. Only pressures that did not result in large-scale hemorrhage were selected for microscopic examination.
Safety assessment: Microscopic evaluation
H&E-stained thin brain sections from samples sonicated with acoustic pressures of 0.30 MPa (n 5 7), 0.46 MPa (n 5 7), 0.61 MPa (n 5 7) and 0.75 MPa (n 5 7) were analyzed under the same bright-field microscope for histological damage. H&E sections from three control brains (no microbubble injection and/or no sonication) were also evaluated. Before the evaluation, adjacent unstained sections (6 mm) were examined under fluorescence microscopy to confirm the presence and extent of the opening at the sonicated location. BBB-opened regions were identified and all 24 H&E sections from the 12 levels were examined accordingly to search for abnormal tissue. For quantification, in the case of each brain, eight sections from eight different levels showing the greatest amount of damage were selected (covering 0.85 mm of hippocampus) and three histological measures were evaluated. The number of dark neurons, number of sites with more than five RBC extravasations, and the number and total area of microvacuolations were counted and calculated for the left (sonicated) and the right control hippocampus in each section. Furthermore, the number of distinct damaged sites (DDS), as a total and composite measure of histological damage per section, was also determined in both the left and right hippocampi. For each histological measure, the values obtained from eight sections were added together and a net difference was calculated as the sum of values from the left hippocampus subtracted from the sum of values in the right hippocampus. The net difference values were averaged across all brains and then plotted, comparing damage at different pressure amplitudes (0.30 to 0.75 MPa) and at two different survival periods (30 min and 5 h). A Student's t-test was used to determine significant difference. A p-value of , 0.05 was considered significant in all comparisons. One DDS was defined as a discrete area of microvacuolation with well-defined borders, a localized region containing more than five damaged neurons or an extravascular region containing localized extravasations of more than five RBCs. A combination of any two or more of the mentioned histological measures at one localized region would also constitute one DDS. Damaged neurons were identified based on characteristics of dark neurons in H&E-stained sections. These neurons had shrunken and triangulated cell bodies, eosinophilic perikaryal cytoplasm and pyknotic basophilic nuclei. In our assessment, the right hippocampus served as the baseline, so its general appearance was taken into account when the left hippocampus was analyzed microscopically, accounting for any artifacts or general poor tissue quality that could have happened because of inadequate fixation, poor tissue handling or processing or because of the experimental procedure itself. As an example, this methodology accounted for the arbitrary decision to count only the sites with five or more extravasated RBCs. In general, extravasations of less than five RBCs in most samples were infrequent and often required a greater amount of time analyzing the sections. In poorly perfused brains, however, detection of a small number of RBCs in different regions was relatively easier and more troublesome, because poor saline perfusion could introduce RBC counting errors. In these brains, RBCs could be detected in small numbers not only in the sonicated region, but also inside and around many microvessels in other regions of the brain. Tissue processing and the plane of sectioning could distort the data count by presenting those few RBCs outside the vessels (that were actually inside). Such artifacts were factored in and only regions with greater than five extravasated RBCs were counted, which most often correlated with the sonication at the left hippocampus. We also applied extra care to avoid the ''dark neuron artifact'' as described by Cammermeyer and others (Cammermeyer 1960 (Cammermeyer , 1978 Jortner 2005) , caused by postmortem trauma as a result of inadequate perfusion fixation or improper tissue handling. Safety analysis was performed by the same trained observer to avoid inconsistency and to reduce assessment error.
Finally, a side-by-side analysis of adjacent unstained and H&E-stained sections was carried out to better understand the mechanism of BBB opening and induced histological damage. First, fluorescence microscopy of unstained sections was performed to provide information on the characteristics of BBB opening based on diffusion of TR dextrans into the brain parenchyma. Then adjacent to the unstained sections, within a 6-80-mm distance, H&E-stained sections were analyzed for any type of damage, especially at the sites of BBB opening detected in unstained sections.
RESULTS
BBB opening threshold
BBB opening occurrence was investigated in brains injected with different tracers such as fluorescent-tagged dextrans (Fig. 2 [a, e] ) and gadolinium (Fig. 2 [c, g, j] ). The threshold for opening was determined as the minimum peak-rarefactional pressure, beyond which 50% opening of the sonicated samples experienced opening. Table 1 shows the percent occurrence of BBB opening in 49 sonicated samples within the acoustic pressure range of 0.15-0.98 MPa. For the lowest acoustic pressure tested (0.15 MPa), there was absence of tracer diffusion in the sonicated regions and therefore no BBB opening occurred (Fig. 2i) . The next tested pressure (0.30 MPa) resulted in BBB opening at a yield of 70% (Fig. 2 [c, j] ). Based on these findings, we have determined the pressure threshold for BBB opening to be within the range of 0.15-0.30 MPa under the conditions used in our study. Fig. 3d ), whereas no hemorrhage was present in the unsonicated right hippocampus. In contrast, samples sonicated at the acoustic pressures of 0.46, 0.61 and 0.75 MPa showed no detectable hemorrhage (Figs. 3 [a, b] ). Therefore, based on gross evaluation, acoustic pressures of 0.98 MPa and higher were considered unsafe and unsuitable for further study. We therefore continued our safety assessment with detailed histology on samples that were sonicated with acoustic pressures of 0.75 MPa and lower.
Microscopic evaluation. Table 2 shows the number of brains studied at various acoustic pressures and different postopening periods in addition to the percentage experiencing BBB opening. H&E sections containing BBBopened regions (as concluded by fluorescence imaging of adjacent unstained sections, Fig. 2 [a, e]) were selected and analyzed for damage. As expected, all control, nonsonicated brains exhibited normal tissue histology at both hippocampi (Fig. 4a) . For the majority of sonicated brains, the control right hippocampus was free of distinct damaged sites (Fig. 4c) , i.e., only a few damaged neurons and scattered RBC extravasations were observed.
At 0.30 MPa, little or no tissue effects were noted in the sonicated samples (Fig. 4b) . A few microvacuolations The damage was detected in 32% of the examined sections. At the acoustic pressures of 0.61 (Fig. 4 [g-i] ) and 0.75 MPa (Fig. 4 [j-l] ), the amount of tissue effects increased considerably and larger regions of microvacuolations, RBC extravasations and neuronal damage were evident (Fig. 5) . The incidence of tissue effects across the examined sections also increased to 66% and 77% in the 0.61 and 0.75 MPa samples, respectively (Fig. 5f ). The characteristics of lesions were similar in all samples but the size and number of lesions generally increased at higher-pressure amplitudes. Within a lesion, microvacuolated areas lacking tissue structure consisted of large and tiny microvacuolations that gave the appearance of nonuniform pores in a focal region within the parenchyma (Figs. 4l and 6e ). If they occurred close to the neuronal cell bodies in pyramidal and granular layers of the hippocampus, they were always accompanied by neuronal damage and sometimes RBC extravasations (Fig. 4 [f, i] ). Dark neurons had darkly stained basophilic nuclei with or without the appearance of shrunken, triangulated and intensely stained acidophilic cell bodies (Fig. 4 [i, l] ).
As stated in Materials and Methods, we used three histological measures to quantify damage for similarlytreated brains sonicated in each pressure amplitude case: (i) average number of dark neurons, (ii) average number of RBC extravasations and (iii) average number and area of microvacuolations. We also used the average number of DDS as a composite histological measure. (Fig. 5 [a-e] ). In the 5-h samples, there was no significant difference among the different pressure amplitudes for all histological measures. The difference in the average area of microvacuolation was also found to be insignificant among all pressure amplitudes and survival periods (Fig. 5d ). In addition, no significant difference between the 30-min and 5-h specimens was observed at all pressure studies for all categories except for the dark neurons, where there was greater damage noted in the case of the 30-min, 0.75-MPa case (Fig. 5a ).
Characterization of BBB disruption and histological damage
In general, two types of fluorescence were observed in the sonicated regions of fluorescence images: (i) a diffuse and relatively uniform distribution of dextrans across the brain parenchyma, with higher levels at the thalamus (Fig. 6a, black stars) ; and (ii) a localized and highly-concentrated leakage of dextrans from larger microvessels (arterioles and venules) branching off of transverse hippocampal arteries and veins (Fig. 6c, black  circle) , or from other microvessels at the hippocampal fissure and thalamus. In most instances, the second type of fluorescence (detected in 0.46-to 0.75-MPa cases) was associated with the greatest damage to the vasculature and surrounding parenchyma. In other words, vascular effects detected in fluorescence images closely matched the nearby DDS that included microvacuolations, necrotic neurons and RBC extravasations ( Fig. 6 [d-f] ). In contrast to the high-intense and patchy fluorescence that was mostly seen in pressure amplitudes of 0.46 MPa and higher, diffused fluorescence was observed in all pressures tested. Only a few of these regions had RBC extravasations (0.3 to 0.75 MPa), dark neurons, small microvacuolations and less dense parenchyma (paler pink; 0.46 to 0.75 MPa). Primarily, however, little or no tissue effects were associated with diffuse BBB opening, especially at lower pressures ( Fig. 6 [d-e] , hollow stars).
Qualitative assessment of BBB disruption and histology in region-specific areas of brain MRI scans of analyzed samples (0.3 to 0.75 MPa) have revealed contrast enhancement in the whole sonicated area, indicating diffuse BBB opening in both the hippocampus and thalamus (Fig. 2 [c, g, j] ). Similar results have been achieved with fluorescence imaging but with some differential fluorescent intensities in a few specific regions. In the majority of the fluorescent samples, BBB opening was more prominent close to the hippocampal fissure and thalamus and around longitudinal and transverse hippocampal arteries. In both imaging modalities, the amount of tracer diffusion varied substantially depending on the peak negative pressure used; higher pressures such as 0.61 and 0.75 MPa consistently resulted in larger areas of tracer diffusion and greater amounts of fluorescence agent (TR-tagged dextrans) and gadolinium. To a lesser extent, BBB disruption was distinguishable with a considerable amount of diffusion at 0.46 MPa, whereas samples sonicated at 0.30 MPa showed BBB opening but with a significant decrease in the amount and extent of tracer diffusion.
In terms of safety assessment, neuronal damage was mainly detected in the pyramidal and granular layers of the hippocampus, whereas RBC extravasations were equally noted around the vessels in both the thalamus and the hippocampus (Fig. 5) . Microvacuolations, on the other hand, were mostly evident in the neuropil of the hippocampus, especially around the microvessels. In some cases, microvacuolations were accompanied by RBC extravasations and dark neurons at a localized area in the hippocampal region, and to a lesser extent in the thalamus. As described in a previous section, distinct damaged sites were mostly associated with patchy BBB opening in the left hippocampal region that lay within the focal region of the ultrasound beam.
DISCUSSION
The aim of this study was to investigate the shortterm safety profile (up to 5 hours post sonication) of the FUS-UCA-induced BBB opening under specific sonication parameters. Particularly, we sought to determine the acoustic pressures that induced BBB opening with no or minimal tissue effects. We performed a combination of fluorescence and bright-field imaging to detect and assess the extent of BBB opening and associated tissue effects in the sonicated locations of the left hippocampal region. We used fluorescent-tagged dextrans and gadolinium as tracers to confirm the opening, H&E staining for safety analysis, three histological measures to quantify the bioeffects and a side-by-side qualitative analysis of adjacent sections to understand the underlying mechanism of induced opening and damage. Our results provide several important findings and insights that are summarized and discussed later.
Under the experimental conditions of our study, the BBB opening pressure threshold was found to be 0.15-0.3 MPa peak negative pressure, based on the fact that 70% (7/10) of the brains (0.30 MPa) underwent opening as confirmed by both MRI and fluorescence imaging ( Fig. 2; Table 1 ). However, this percentage combined the results of both imaging modalities used to detect opening. The sizes of Omniscan (573.7 Da) and dextrans (3000 Da) are different in magnitude, so there may be a higher-percent opening when only gadolinium is used. Indeed, lack of opening in three out of the 10 samples was observed only in brains, where dextrans were injected after sonication. It is very likely that the threshold of BBB opening is in fact at 0.3 MPa, with 100% probability for compounds smaller than 3 kDa. The absence of opening at 0.15 MPa as imaged via MRI ( Fig. 2i ; Table 1 ) and confirmed by other studies ) and the presence of BBB opening in 77% (10/13) of 0.46-MPa samples also support this finding. Whether a 0.15-to 0.3-MPa threshold holds true for greater molecular weight compounds, different sonication parameters and different protocols remains to be confirmed.
Gross evaluation of thick brain slices sonicated with 0.46-0.98 MPa ranging pressures revealed large-scale detectable hemorrhage only in the 0.98-MPa case, hence eliminating pressure amplitudes of higher than 0.75 MPa from further study. Thorough microscopic examination of thin H&E-stained sections from 0.3-0.75 MPa sonicated brains showed minimal tissue effects in 0.3-and 0.46-MPa samples, whereas at 0.61-and 0.75-MPa acoustic pressures, multiple distinct damaged sites with higher frequency of occurrence were detected (66 and 76% of studied sections, respectively; Fig. 5f ). As described previously, DDS was defined to incorporate microvacuolations, necrotic neurons and RBC extravasations in one single measure. This composite measure of histological damage provided higher accuracy, greater consistency and less subjective analysis of safety across different brain samples. Two different histologists may disagree on the exact number of dark neurons or microvacuolations present, but they are more likely to agree on the number of distinct damaged areas in the same section. In all analyzed samples (30-min and 5-h), the average number of distinct damaged sites increased by 5-, 11-and 15-fold in the 0.46-, 0.61-and 0.75-MPa samples, respectively, compared with the 0.3-MPa samples (Fig. 5e, black bar) . However, the differences in the average numbers were statistically significant (p , 0.05) only between the 0.75-MPa and 0-0.3 MPa cases. Similar significance was also observed in the average number of microvacuolations and RBC-extravasated sites. Comparison of data from different survival periods indicated that increasing acoustic pressures from 0.3-0.75 MPa resulted in no significant increase in tissue effects when histology was assessed after 5 h of survival. Moreover, the number of lesions did not increase or decrease significantly when 30-min samples were compared with the 5-h samples (one exception was the decrease in the number of dark neurons at 0.75 MPa between the 30-min and 5-h samples; Fig. 5a ). This suggests that the effects of the FUS-UCA interaction on the vasculature and surrounding tissue are immediate and not cumulative over time. Moreover, significant decrease in the number of dark neurons at 0.75 MPa could indicate that neuronal injury is more severe at this pressure amplitude compared with lower pressures, possibly because of associated prolonged ischemia. It is likely that necrotic cells are cleared quickly within the first few hours of sonication, lowering their detection level after 5 h. It should be noted that although histologically there was no significant difference in tissue effects between 30-min and 5-h samples, there is a possibility that the initial damage caused by higher-pressure amplitudes may bring about long-term behavioral, functional or pathological changes that have not been observed or quantified yet. Further studies are needed for a better understanding of damage/repair mechanisms that come into effect after the sonication. Based on these results, we can only claim that pressure amplitudes of 0.3-0.46 MPa have shown the least amount of tissue effects (while successfully opening the BBB) at both tested time periods within the 5-h window (30-min and 5-h).
Our side-by-side analysis of BBB opening in the hippocampal region (as detected by fluorescence microscopy) and the histological damage in that area (as assessed by H&E staining) demonstrated a close association between the types of observed fluorescence and the types and extent of tissue effects. The majority of distinct damaged sites were detected near severely affected Inertial cavitation of microbubbles as a result of FUS exposure may contribute to the vascular effects that were described here, whereas noninertial cavitation of microbubbles may cause a uniformly diffuse BBB opening. Several studies directly support this notion. In a recent vessel phantom study reported by our group , the inertial cavitation threshold of Definity microbubbles was determined to be 0.46 MPa. Preliminary results of in vivo studies by our group are also in agreement with this finding ). The significance of 0.4-0.46 MPa as the inertial cavitation threshold of microbubbles becomes evident when histological findings are taken into account. At 0.3 MPa, the tissue effects were limited to a few scattered RBC extravasations and very few small microvacuolated areas (18% of sections; Figs. 4b and 5f). Starting at 0.46 MPa, however, the presence of distinct damaged sites consisting of several types of damage in one local region (32% of sections; Fig. 4 [df] ) was noted. The fact that the average numbers of DDS, microvacuolations and RBC extravasations were significantly higher at 0.75 MPa, with respect to 0.3 MPa but not 0.46 MPa (Fig. 5 [b, c, e] ), supports this assertion, i.e., inertial cavitation and its related effects was triggered at 0.46 MPa and beyond. Recent in vivo cavitation studies performed by our group further support this hypothesis Tung et al. 2010b) . It is also noteworthy to mention that, despite the differences in some experimental parameters compared with our study (such as frequency), Hynynen et al. reported similar findings regarding the BBB opening threshold and damage McDannold et al. 2007) . In a study with Optison microbubbles (frequency 0.26 MHz, burst length 10 ms, PRF 1 Hz), an acoustic pressure of 0.2 MPa was determined as the BBB opening threshold Hynynen et al. 2006) . Eighty percent BBB opening occurred at 0.3 MPa, and tissue damage was apparent at 0.4 MPa and higher . Hence, these results and our current findings are consistent with the fact that BBB opening can occur without inertial cavitation as detected by wideband acoustic emission in vivo.
The type of microbubble activity that results from an interaction with the ultrasound beam is likely to be the major contributing factor to the underlying mechanism of BBB opening and associated damage. First, it is predicted that the inertial cavitation of microbubbles and their collapse in an ultrasound field may produce forceful fluid jets and shock waves against the vessel walls, with direct and indirect mechanical stress on the tight junctions of the endothelial cells, thereby severely disrupting the anatomical barrier at that location Leighton 1994) . This can cause extensive leakage of molecules from the lumen, including RBCs and tracer molecules (hence, the intense fluorescence of dextrans). Distal to the severed vessels, where there is reduced blood flow, ischemic regions may undergo acute necrosis and tissue deterioration (CharriautMarlangue et al. 1998; Chen et al. 1997; Kogure 1997; Li et al. 1998; Macdonald and Stoodley 1998; Rosenblum 1997) . It is likely that the dark necrotic neurons and the microvacuolated neuropil presented here are the results of such ischemic episodes. Noninertial cavitation of microbubbles, on the other hand, is thought to act on small arterioles and capillaries, where radiation forces and mechanical forces from bubble oscillations ) and acoustic streaming (Hynynen 2008 ) may be translated to modified signal transduction at the endothelial cell surface, promoting transcellular transport of molecules or their paracellular passage by reducing the expression of tight-junctional proteins. Understanding of this mechanism may help unveil the type of physiological disruption of the BBB, with fewer damaging effects on the vasculature and the surrounding tissue.
Based on the findings reported in this paper, we believe that with the correct combination of sonication parameters we will be able to reduce the number of severely damaged vessels by operating under the inertial cavitation threshold. Preliminary studies by our group indicate that reducing the PRF may reduce patchy regions while promoting a more diffuse opening of the BBB. A reduced number of pulses may allow the microbubbles to enter the hippocampus and the capillaries, resulting in fewer concentrated bubbles at the arteriolar level. It is still critical that lower peak negative pressures such as 0.3-0.46 MPa are used to decrease microbubble cavitation activity and minimize undesired tissue effects.
Finally, our safety assessment is limited in several respects. First, H&E staining is not sufficient to fully understand the scope of histological damage because axons, glial cells and inflammatory molecules are difficult to detect and identify in H&E-stained sections. As a result, additional staining of the affected tissue is needed for H&E validation (such as TUNEL) as will be performed in future studies. Second, the eight sections that were analyzed (from 12 separate levels spanning the entire hippocampus) may underestimate the actual damage because of the 80-mm spacing between neighboring levels, in addition to the rest of the brain outside the 12 levels studied.
This study focused on short-term histological assessment of FUS-UCA-induced BBB opening in mice. Our study is only a step toward understanding the safety of FUS-UCA and the short-term risks that it presents. Ongoing studies will address the safety of the procedure after longer survival times (up to 7 d). Moreover, assessment of the procedure's safety profile is incomplete without performing long-term behavioral and functional studies (electroencephalogram, evoked potentials, etc.) after sonication. For better accuracy, physiological monitoring of factors that may contribute to brain injury from ischemia in a larger species will be undertaken in follow-up studies. Finally, the acoustic parameters need to be optimized for maximum diffuse BBB opening at the targeted region and minimal anatomical and physiological damage.
CONCLUSION
Under the specific parameters used in this study, we determined the threshold for BBB opening to be between 0.15 and 0.3 MPa. Comparison between the 30-min and 5-h histological findings across all tested pressures showed no significant difference in tissue effects between the two cases. For both survival time periods (30 min and 5 h), it was only the lower-pressure amplitudes that showed the least amount of short-term effects (0.3 to 0.46 MPa). Side-by-side analysis of BBB opening, as detected by fluorescence imaging MRI and histology revealed two types of fluorescence intensity changes and associated tissue effects: (i) an intensely localized disruption with nearby vascular effects and distinct damaged sites and (ii) a mildly diffuse opening across the brain parenchyma with minimal tissue deterioration. Thus, we conclude that selecting the appropriate sonication parameters can eliminate, or significantly reduce, the severity of BBB disruption in the affected microvessels while resulting in a diffuse and safe opening of the BBB.
